Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SEB Enskilda, formerly known as Enskilda Securities, was a prominent Nordic investment bank and a subsidiary of Skandinaviska Enskilda Banken (SEB). Headquartered in Stockholm, the firm specialized in corporate finance, equity research, and brokerage services, maintaining a dominant position in the Scandinavian capital markets for several decades. It was particularly active in advising on mergers, acquisitions, and initial public offerings, including many high-profile transactions in the life sciences and technology sectors. In the early 2000s, the entity was fully integrated into SEB's Merchant Banking division, and the standalone Enskilda brand was eventually retired. Despite its involvement in financing healthcare companies as an advisor, SEB Enskilda itself is a financial services provider and not a biotechnology or pharmaceutical entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enskilda Securities.